Surface charge The surface charge of liposomes would be of impor-
tant consideration for appropriate vaccine design. The
overall charge can determine the adsorption or antigen
interaction with the liposomes (e.g. anionic antigens
will prefer to interact with cationic lipids) which affects
antigen loading in the vaccine [
18
]. Hussain et al. found
that replacing the cationic lipid DDA with the neutral
lipid distearoyl-sn-glycero-3-phosphocholine (DSPC)
decreases the amount of the tuberculosis recombinant
antigen H56 from 84 down to 15%. In addition, the func-
tion of the vaccine in relation to immune response induc-
tion is well documented. Joseph et al. were studying an
intranasal influenza vaccine model based on the lipo-
somal formulation of the HN antigen with the polyca-
tionic sphingolipid ceramide carbamoyl-spermine (CCS)
or other monocationic, neutral and anionic lipids [
45
].
Neutral and anionic lipid-based formulations were not
immunogenic upon intranasal administration in a murine
model. However, two out of five monoccationic-based
liposomal formulations (containing lipids 1,2-dimyris-
toyl-3-trimethylammonium-propane, DMTAP; and
1,2-dioleoyl-3-trimethylammonium-propane, DOTAP)
induced vigorous local and systemic immune responses
(T
H
1 and T
H
2 type responses). Researchers compared
the monocationic liposomal formulations with the
CCS-based liposomal formulation and the only com-
mercially available influenza vaccine, demonstrating
the efficacy of the sphingolipid as an immunopotentia-
tor with higher antibody titers and protective immunity
for approximately 9 months. Another study with New-
castle disease virus compared the immunization effects
in chickens of neutrally- (EPC-Lip), anionically- (PS-
Lip) and cationically-charged (SA-Lip) liposomes [
46
].
Strong humoral responses (local and systemic) were
observed in neutral formulations of EPC-Lip, contrasting
to the cationic SA-Lip. The anionic formulation mainly
composed of phosphatidyl serine (PS-Lip) elicited the
higher hemagglutination titers. Recently, Hussain et al.
determined that replacing the cationic lipid DDA with
the neutral DSPC reduced the T
H
1-mediated immune
response of the formulation [
18
]. Based on the studies
presented above we can conclude that cationic formula-
tions might be the most suitable option to elicit strong
immune responses, increasing antibody titers. There is
additional information available about cationic lipids, like
DDA, which possess significant immunostimulatory and
adjuvanting properties [
47
,
48
] and further explanations
will be provided ahead.